EDITORIAL CONTACT
Contact TB-500 Source
For corrections, citations and editorial questions about the research record.
What this form is for
Use this form for editorial correspondence about TB-500 Source: corrections, citation questions, requests to clarify how a finding was tagged (fragment versus full-length thymosin beta-4), or notes on a study we should add to the ledger. We read everything that concerns the accuracy of the record.
We are an independent editorial project. We do not provide medical or legal advice, we do not respond to requests for dosing or administration guidance, and we cannot help anyone obtain TB-500 or any other compound. There is no clinic, pharmacy, or vendor behind this site, and nothing here is dispensed or sold.
What we cannot answer
We cannot recommend a dose, a protocol, a route, or a supplier, and we will not advise on obtaining a substance outside the lawful framework. Questions about whether TB-500 is appropriate for an individual are clinical questions for a licensed prescriber, not editorial ones for us.
For the regulatory standing — FDA non-approval, the 503A Category 2 flag, and the WADA-prohibited status — the legal-status page states the present-tense facts from primary sources. If you believe a regulatory fact on this site is out of date, send the FDA or WADA citation and we will reconcile it.